Tokyo Tape
Sign in
← I'rom Group

Quarterly report · Q2

2372.TEDINET S100PFYJ
Period2022-04-01 → 2022-09-30
Filed2022-11-04
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
MetricValuePeriodScopeSource row
Revenue¥9.6bn2022-04-01 → 2022-09-30Cons.Net sales
Revenue¥15.7bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥6.8bn2021-04-01 → 2021-09-30Cons.Net sales
Operating income¥2.4bn2022-04-01 → 2022-09-30Cons.Operating income
Operating income¥858m2021-04-01 → 2021-09-30Cons.Operating income
Ordinary income¥2.5bn2022-04-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥2.6bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥994m2021-04-01 → 2021-09-30Cons.Ordinary income
Profit before tax¥2.6bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥1.0bn2021-04-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥2.0bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.0bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥723m2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income¥2.0bn2022-04-01 → 2022-09-30Cons.Profit loss
Net income¥721m2021-04-01 → 2021-09-30Cons.Profit loss
Total assets¥30.4bnat 2022-09-30Cons.Assets
Total assets¥26.6bnat 2022-03-31Cons.Assets
Total assets¥22.7bnat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥18.5bnat 2022-09-30Cons.Liabilities
Total liabilities¥16.4bnat 2022-03-31Cons.Liabilities
Net assets / equity¥12.0bnat 2022-09-30Cons.Net assets
Net assets / equity¥10.2bnat 2022-03-31Cons.Net assets
Net assets / equity¥9.0bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥7.0bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥6.4bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥7.0bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥6.4bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥5.0bnat 2021-09-30Cons.Cash and cash equivalents
Cash & equivalents¥3.9bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥2.5bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥2.6bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥653m2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥2.7bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥2.9bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥1.3bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in investment activities
Financing cash flow¥740m2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow¥2.7bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.9bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥164.172022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥75.82022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥162.52021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥59.992021-04-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥38.52021-07-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥163.912022-04-01 → 2022-09-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥162.172021-04-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥59.852021-04-01 → 2021-09-30Cons.Diluted earnings per share (5-year summary)
Equity ratio39.2%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio38.1%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio39.4%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 62
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-09-30¥68m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-09-30¥28m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-09-30¥39m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-09-30−¥118m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥641m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥641m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥673m
jpcrp040300-q2r_E05352-000Advanced Medicalreportable segmentrevenue2022-04-01 → 2022-09-30¥619m
jpcrp040300-q2r_E05352-000Advanced Medicalreportable segmentrevenue external2022-04-01 → 2022-09-30¥618m
jpcrp040300-q2r_E05352-000Advanced Medicalreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥1m
jpcrp040300-q2r_E05352-000Advanced Medicalreportable segmentsegment profit2022-04-01 → 2022-09-30−¥181m
jpcrp040300-q2r_E05352-000CROreportable segmentrevenue2022-04-01 → 2022-09-30¥2.8bn
jpcrp040300-q2r_E05352-000CROreportable segmentrevenue external2022-04-01 → 2022-09-30¥2.7bn
jpcrp040300-q2r_E05352-000CROreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥88m
jpcrp040300-q2r_E05352-000CROreportable segmentsegment profit2022-04-01 → 2022-09-30¥82m
jpcrp040300-q2r_E05352-000Medical Supportreportable segmentrevenue2022-04-01 → 2022-09-30¥953m
jpcrp040300-q2r_E05352-000Medical Supportreportable segmentrevenue external2022-04-01 → 2022-09-30¥503m
jpcrp040300-q2r_E05352-000Medical Supportreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥449m
jpcrp040300-q2r_E05352-000Medical Supportreportable segmentsegment profit2022-04-01 → 2022-09-30¥24m
jpcrp040300-q2r_E05352-000SMOreportable segmentrevenue2022-04-01 → 2022-09-30¥5.8bn
jpcrp040300-q2r_E05352-000SMOreportable segmentrevenue external2022-04-01 → 2022-09-30¥5.7bn
jpcrp040300-q2r_E05352-000SMOreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥61m
jpcrp040300-q2r_E05352-000SMOreportable segmentsegment profit2022-04-01 → 2022-09-30¥3.3bn
—segment totalrevenue2022-04-01 → 2022-09-30¥10.2bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥9.6bn
—segment totalrevenue intersegment2022-04-01 → 2022-09-30¥601m
—segment totalsegment profit2022-04-01 → 2022-09-30¥3.2bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥10.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥9.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-09-30¥641m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥3.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-09-30¥32m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-09-30¥8m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2021-09-30¥23m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-09-30−¥100m
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-09-30−¥492m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-09-30−¥492m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-09-30−¥658m
jpcrp040300-q2r_E05352-000Advanced Medicalreportable segmentrevenue2021-04-01 → 2021-09-30¥294m
jpcrp040300-q2r_E05352-000Advanced Medicalreportable segmentrevenue external2021-04-01 → 2021-09-30¥291m
jpcrp040300-q2r_E05352-000Advanced Medicalreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥2m
jpcrp040300-q2r_E05352-000Advanced Medicalreportable segmentsegment profit2021-04-01 → 2021-09-30−¥311m
jpcrp040300-q2r_E05352-000CROreportable segmentrevenue2021-04-01 → 2021-09-30¥2.4bn
jpcrp040300-q2r_E05352-000CROreportable segmentrevenue external2021-04-01 → 2021-09-30¥2.4bn
jpcrp040300-q2r_E05352-000CROreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥29m
jpcrp040300-q2r_E05352-000CROreportable segmentsegment profit2021-04-01 → 2021-09-30¥240m
jpcrp040300-q2r_E05352-000Medical Supportreportable segmentrevenue2021-04-01 → 2021-09-30¥856m
jpcrp040300-q2r_E05352-000Medical Supportreportable segmentrevenue external2021-04-01 → 2021-09-30¥497m
jpcrp040300-q2r_E05352-000Medical Supportreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥359m
jpcrp040300-q2r_E05352-000Medical Supportreportable segmentsegment profit2021-04-01 → 2021-09-30¥123m
jpcrp040300-q2r_E05352-000SMOreportable segmentrevenue2021-04-01 → 2021-09-30¥3.8bn
jpcrp040300-q2r_E05352-000SMOreportable segmentrevenue external2021-04-01 → 2021-09-30¥3.7bn
jpcrp040300-q2r_E05352-000SMOreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥77m
jpcrp040300-q2r_E05352-000SMOreportable segmentsegment profit2021-04-01 → 2021-09-30¥1.6bn
—segment totalrevenue2021-04-01 → 2021-09-30¥7.3bn
—segment totalrevenue external2021-04-01 → 2021-09-30¥6.8bn
—segment totalrevenue intersegment2021-04-01 → 2021-09-30¥468m
—segment totalsegment profit2021-04-01 → 2021-09-30¥1.6bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-09-30¥7.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-09-30¥6.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-09-30¥492m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-09-30¥1.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 548
ItemContextValueUnit
Current portion of long term loans payablePrior1YearInstant1329000000JPY
Current portion of long term loans payableCurrentQuarterInstant1548000000JPY
Income taxes payablePrior1YearInstant356000000JPY
Income taxes payableCurrentQuarterInstant561000000JPY
Contract liabilitiesPrior1YearInstant356000000JPY
Contract liabilitiesCurrentQuarterInstant414000000JPY
Advances receivedPrior1YearInstant86000000JPY
Advances receivedCurrentQuarterInstant77000000JPY
Lease obligations clPrior1YearInstant147000000JPY
Lease obligations clCurrentQuarterInstant143000000JPY
Other clPrior1YearInstant1257000000JPY
Other clCurrentQuarterInstant1818000000JPY
Current liabilitiesPrior1YearInstant7435000000JPY
Current liabilitiesCurrentQuarterInstant8589000000JPY
Long term loans payablePrior1YearInstant7200000000JPY
Long term loans payableCurrentQuarterInstant8105000000JPY
Deferred tax liabilitiesPrior1YearInstant1000000JPY
Deferred tax liabilitiesCurrentQuarterInstant8000000JPY
Asset retirement obligations nclPrior1YearInstant149000000JPY
Asset retirement obligations nclCurrentQuarterInstant150000000JPY
Guarantee deposits received2 nclPrior1YearInstant352000000JPY
Guarantee deposits received2 nclCurrentQuarterInstant355000000JPY
Net defined benefit liabilityPrior1YearInstant172000000JPY
Net defined benefit liabilityCurrentQuarterInstant171000000JPY
Lease obligations nclPrior1YearInstant1067000000JPY
Lease obligations nclCurrentQuarterInstant1043000000JPY
Other nclPrior1YearInstant46000000JPY
Other nclCurrentQuarterInstant41000000JPY
Noncurrent liabilitiesPrior1YearInstant8991000000JPY
Noncurrent liabilitiesCurrentQuarterInstant9876000000JPY
LiabilitiesPrior1YearInstant16426000000JPY
LiabilitiesCurrentQuarterInstant18466000000JPY
Capital stockPrior1YearInstant3879000000JPY
Capital stockCurrentQuarterInstant3899000000JPY
Capital surplusPrior1YearInstant1466000000JPY
Capital surplusCurrentQuarterInstant1485000000JPY
Retained earningsPrior1YearInstant5099000000JPY
Retained earningsCurrentQuarterInstant6780000000JPY
Treasury stockPrior1YearInstant-423000000JPY
Treasury stockCurrentQuarterInstant-423000000JPY
Shareholders equityPrior1YearInstant10021000000JPY
Shareholders equityCurrentQuarterInstant11740000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant68000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant141000000JPY
Foreign currency translation adjustmentPrior1YearInstant38000000JPY
Foreign currency translation adjustmentCurrentQuarterInstant59000000JPY
Valuation and translation adjustmentsPrior1YearInstant107000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant200000000JPY
Subscription rights to sharesPrior1YearInstant17000000JPY
Subscription rights to sharesCurrentQuarterInstant－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass